ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 76627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 76627; 2) Community: the network communities that were significantly associated with the response to NSC 76627; 3) Molecule: the relationships between components within communities and NSC 76627; 4) MDR: the compounds that were significantly associated with the NSC 76627.

NSC Compound Enrichment Correlation
NSC 694488 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 3-(acetoxymethyl)- 0.00229763127300112 -0.14517367
NSC 79543 Pyridinium, 5-ethyl-2-[2-(8-hydroxy-5-quinolyl)vinyl]-1-methyl- iodide 0.00306027196853058 0.31174995
NSC 529108 4-Fluoro-D,L-tryptophan 0.00306027196853062 0.064399218
NSC 61900 Null 0.00306027196853062 0.15642466
NSC 661470 Null 0.00306027196853062 -0.059770887
NSC 675799 Null 0.00306027196853062 0.09481739
NSC 723428 2-(para-methoxyphenyl)-1-[(6-bromo-2-(2-thienyl)-4- quinazolinyl]-1,4-dihydro-5H-1,3,4-benzotriazepine-5-one 0.00306027196853062 -0.072670931
NSC 729518 Null 0.00306027196853062 -0.15952859
NSC 140380 Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) 0.00311751113090891 0.17153142
NSC 33566 Null 0.00311751113090891 0.03637966
Total:71  Current:6    [First] [Prev] [Next] [Last]